Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA

Contraception

Volumn 75, Issue 2, 2007, Pages 84-87

  Nelson, Anita L ^a   Katz, Tyler ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Access; Continuation rate; DMPA; Hormonal contraception; Same day injection

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH CENTER; HEALTH SERVICE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENSTRUAL CYCLE; POPULATION RESEARCH; PREGNANCY;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, POSTCOITAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUAL CYCLE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33846247940     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.09.007     Document Type: Article

References (13)

1. Westhoff C., Kerns J., Morroni C., Cushman L.F., Tiezzi L., and Murphy P.A. Quick start: novel oral contraceptive initiation method. Contraception 66 (2002) 141-145
2. Depo-Provera® Contraceptive Injection. Full U.S. Prescribing Information. Revised 2004 Nov. Accessed 6/12/06 at. http://www.pfizer.com/pfizer/download/uspi_depo_provera_contraceptive.pdf
3. WHO Reproductive Health and Research. Selected practice recommendations for contraceptive use. 2nd ed. (2004), World Health Organization, Geneva. http://www.who.int/reproductive-health/publications/spr/index.htm Accessed 12/13/05 at
4. Petta C.A., Faundes A., Dunson T.R., et al. Timing of onset of contraceptive effectiveness in Depo-Provera users: part I. Changes in cervical mucus. Fertil Steril 69 (1998) 252-257
5. Borgatta L., Murthy A., Chuang C., Beardsley L., and Burnhill M.S. Pregnancies diagnosed during Depo-Provera use. Contraception 66 (2002) 169-172
6. Sneed R., Westhoff C., Morroni C., and Tiezzi L. A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection. Contraception 71 (2005) 99-103
7. Balkus J., and Miller L. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review. Contraception 71 (2005) 395-398
8. Rickert V.I., Tiezzi L., León J., Lipshutz J., Vaughan R.D., and Westhoff C. Depo now: preventing unintended pregnancies among adolescents. J Adolesc Health 38 (2006) 96 [Abstract]
9. Davidson A.R., Kalmuss D., Cushman L.F., Romero D., Heartwell S., and Rulin M. Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women. Am J Public Health 87 (1997) 1532-1534
10. Paul C., Skegg D.C., and Williams S. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation. Contraception 56 (1997) 209-214
11. Potter L.S., Dalberth B.T., Canamar R., and Betz M. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department. Contraception 56 (1997) 305-312
12. Polaneczky M., and Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 23 (1998) 81-88
13. Zibners A., Cromer B.A., and Hayes J. Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol 12 (1999) 90-94